Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous (VIGIV)

NCT01158157 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT01158157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01158157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous (VIGIV)
Lead sponsor
Emergent BioSolutions
Phase
Phase 3
Overall status
Completed
Start date
September 13, 2010
Completion date
February 14, 2012
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smallpox vaccine adverse reaction